Daniel Lynch
Affiliations
- at 2Seventy Bio Inc. (TSVT), 2023-06-15
- Director at Springworks Therapeutics Inc. (SWTX), 2023-05-25
- Director at Bluebird Bio Inc. (BLUE), 2021-11-17
- Large Shareholder, Director at Xilio Therapeutics Inc. (XLO), 2021-10-22
- Director at Translate Bio Inc. (TBIO), 2021-02-16
- Director at Omega Alpha Spac (OMEG), 2021-01-07
- Director at Blueprint Medicines Corp (BPMC), 2020-06-26
- Director at Surface Oncology Inc. (SURF), 2020-06-12
- Director at Sesen Bio Inc. (SESN), 2019-06-21
- Director, Other at Dnib Unwind Inc. (BIND), 2016-08-30
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| BPMC | $80.42 | 12,500 | Director | 174,342 | 2018-02-14 | Filing | |
| BPMC | $73.27 | 3,996 | Director | 186,842 | 2018-02-12 | Filing | |
| BPMC | $74.31 | 3,748 | Director | 190,838 | 2018-02-12 | Filing | |
| BPMC | $75.15 | 5,636 | Director | 194,586 | 2018-02-12 | Filing | |
| BPMC | $75.96 | 2,590 | Director | 200,222 | 2018-02-12 | Filing |